Table 4 |
||
|
Medical Costs |
||
|
Diabetic Neuropathy (DN) Cohort Compared to Diabetes (DM) Cohort |
||
|
|
||
|
Cost Component |
Comparative Costs |
P Value |
|
|
||
|
Total Direct Medical Costs |
$4819.29 v $24,764.91 |
* |
|
Inpatient Costs |
$1,004.78 v $7,282.16 |
* |
|
Outpatient Costs |
$2,548.09 v $14,137.98 |
* |
|
ER Costs |
$178.28 v $889.25 |
* |
|
Pharmaceutical Costs |
$1,098.28 v $5,622.53 |
* |
|
Diabetes-Related Total Direct Medical Costs |
$1,296.79 v $5,125.10 |
* |
|
|
||
|
Diabetes and Depression (DD) Cohort Compared to Diabetes (DM) Cohort |
||
|
|
||
|
Cost Component |
Comparative Costs |
P Value |
|
|
||
|
Total Direct Medical Costs |
$4,819.29 v $19,397.59 |
* |
|
Inpatient Costs |
$1,004.78 v $3,644.51 |
* |
|
Outpatient Costs |
$2,548.09 v $10,895.46 |
* |
|
ER Costs |
$178.28 v $833.85 |
* |
|
Pharmaceutical Costs |
$1,098.28 v $6,526.86 |
* |
|
Diabetes-Related Total Direct Medical Costs |
$1,296.79 v $3,263.81 |
* |
|
|
||
|
Diabetic Neuropathy (DN) Cohort Compared to Diabetes and Depressed (DD) Cohort |
||
|
|
||
|
Cost Component |
Comparative Costs |
P Value |
|
|
||
|
Total Direct Medical Costs |
--- |
NS |
|
Inpatient Costs |
$3,011.01 v $4,167.12 |
** |
|
Outpatient Costs |
$8,109.09 v $8,861.53 |
*** |
|
ER Costs |
--- |
NS |
|
Pharmaceutical Costs |
--- |
NS |
|
Diabetes-Related Total Direct Medical Costs |
$2,783.23 v $3,455.54 |
* |
|
|
||
|
Results from ordinary least squares, stepwise regressions controlling for age, sex, region, insurance type, and comorbidities (hypertension, hyperlipidemia, cardiovascular disease, ischemic heart disease, and obesity) using log of costs as the dependent variable. *P-value ≤ 0.0001; **P-value ≤ 0.001; ***P-value ≤ 0.05 |
||
|
Le et al. Cost Effectiveness and Resource Allocation 2006 4:18 doi:10.1186/1478-7547-4-18 |
||
